GGrantIndex
← Search

ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION

$1,499,999N01FY2022AINIH

Hbvtech, Germantown MD

Investigators

Abstract

To support a Phase II proposal to develop a new hepatitis B virus (HBV) cure drug. The Phase II proposal seeks to expand on the development of the lead compound supported under a Phase I study.

View original record on NIH RePORTER →